Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences
In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on …
Emerging Technologies
Biopharmaceutical industry and healthcare are being transformed by a variety of novel technolgies coming into research and business practises. From artificial intelligence and big data tools, to quantum computing, next generation proteomics, and virtual reality -- novel technologies are disrupting the traditional research and business models, and helping innovate at a greater scale, faster, and cheaper.
17 Companies Building the Future of Drug Development on a Chip
In the early 2000s, the concept of organ-on-a-chip technology, also known as microphysiological systems, emerged as a way to replicate …
On Biotech Engineering and AI: a Conversation with TeselaGen's CEO, Eduardo Abeliuk
Navigating the dynamic intersection of biology and data science, Eduardo Abeliuk, the CEO of TeselaGen Biotechnology, invites us on a …
How Big Pharma Adopts AI To Boost Drug Discovery
(Last updated: July 2023) The type of artificial intelligence (AI) which scares business leaders, experts, and activists all over the …
How AI-Driven Multi-Omics is Reshaping Drug Discovery
The fusion of artificial intelligence (AI) with multi-omics - a comprehensive study encompassing genomics, transcriptomics, proteomics, metabolomics, and other related …
Beyond Animal Testing: Organ-on-a-Chip Companies Usher in a New Era for Drug Trials
Nearly two decades ago, a groundbreaking discovery in the field of biomedical research emerged, known as organ-on-a-chip technology, which quickly …
How to Discover a Preclinical Drug Candidate in Two Years
Recent advances in artificial intelligence (AI) has played a pivotal role in optimizing the small-molecule synthesis, standardization, scalability and CRO-based …
Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …
The Rising Role of AI-enabled Digital Pathology in Drug Discovery
The field of pathology has experienced a major shift over the past few decades. This evolution began as early as …
Collaboration Between Iktos and Curreio Harnesses AI and Cryo-EM for Drug Discovery
Iktos, a French AI-focused company specializing in new drug design, and Curreio, a Japanese cryo-electron microscopy (cryo-EM) expert, have recently …
CEPI and aVaxziPen Partner to Advance Needle-Free Vaccine Delivery Aiming for Equitable Global Access
Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving …
Owkin Advances AI in Drug Discovery with Launching $50 Million MOSAIC Project
Owkin, an AI biotech firm, is partnering with NanoString Technologies and other notable cancer research institutions to spearhead the MOSAIC …
